In addition, we downregulated the expression of PGE2 by celecoxib treatment in FADS1-OE xenograft mouse models and found celecoxib could inhibit the FADS1-driven tumor growth (Supplementary Fig. 7). Here, FADS1 is linked to neoplasm.